FI3934637T3 - (N)-asetyyli-L-leusiini käytettäväksi traumaattisen aivovaurion hoitamisessa - Google Patents
(N)-asetyyli-L-leusiini käytettäväksi traumaattisen aivovaurion hoitamisessa Download PDFInfo
- Publication number
- FI3934637T3 FI3934637T3 FIEP20712029.6T FI20712029T FI3934637T3 FI 3934637 T3 FI3934637 T3 FI 3934637T3 FI 20712029 T FI20712029 T FI 20712029T FI 3934637 T3 FI3934637 T3 FI 3934637T3
- Authority
- FI
- Finland
- Prior art keywords
- leucine
- acetyl
- pharmaceutically acceptable
- acceptable salt
- subject
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962812987P | 2019-03-02 | 2019-03-02 | |
| US201962842296P | 2019-05-02 | 2019-05-02 | |
| US201962888894P | 2019-08-19 | 2019-08-19 | |
| US201962895144P | 2019-09-03 | 2019-09-03 | |
| PCT/IB2020/051767 WO2020178721A1 (en) | 2019-03-02 | 2020-03-02 | Leucine, acetyl leucine, and related analogs for treating disease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3934637T3 true FI3934637T3 (fi) | 2024-09-02 |
Family
ID=69845470
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP20712029.6T FI3934637T3 (fi) | 2019-03-02 | 2020-03-02 | (N)-asetyyli-L-leusiini käytettäväksi traumaattisen aivovaurion hoitamisessa |
Country Status (25)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201709459D0 (en) | 2017-06-14 | 2017-07-26 | Intrabio Ltd | Treatment for migraine |
| CN120157593A (zh) | 2018-12-06 | 2025-06-17 | 内在生物技术有限公司 | 乙酰基-亮氨酸的氘代类似物 |
| MD3989962T2 (ro) | 2019-06-28 | 2025-12-31 | Intrabio Ltd Gb | Terapie combinată cu acetil-leucină și miglustat pentru tratamentul unei boli de depozitare lizozomală |
| WO2021144720A1 (en) | 2020-01-13 | 2021-07-22 | Intrabio Ltd | Treatment of late-onset neurodegenerative diseases in heterozygous npc1 gene mutation carriers |
| WO2022125304A1 (en) * | 2020-12-10 | 2022-06-16 | Texas Tech University System | Bcaa-lowering compounds for prevention and/or treatment of alzheimer's disease and related disorders |
| WO2022264037A1 (en) * | 2021-06-14 | 2022-12-22 | Intrabio Ltd. | Branched-chain amino acid derivatives to treat disease |
| WO2024243004A2 (en) * | 2023-05-19 | 2024-11-28 | The Children's Hospital Of Philadelphia | Compositions and methods for treating traumatic brain injury |
| WO2025166100A1 (en) * | 2024-02-02 | 2025-08-07 | SynGAP Research Fund | Compositions and methods for treating neurodevelopmental disorders |
| WO2025175092A1 (en) * | 2024-02-14 | 2025-08-21 | Intrabio Inc. | Acetyl leucine for treating syngap1-related disorders |
| TW202604470A (zh) * | 2024-06-20 | 2026-02-01 | 美商音特拉拜歐公司 | 乙醯白胺酸用於治療神經發育障礙 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060063827A1 (en) * | 2004-09-23 | 2006-03-23 | Yu Ruey J | Systemic administration of therapeutic amino acids and N-acetylamino acids |
| FR2905600B1 (fr) * | 2006-09-13 | 2010-01-15 | Pf Medicament | Traitement des vertiges par l'acetyl-l-leucine. |
| TN2010000251A1 (fr) * | 2010-06-03 | 2011-11-11 | Rekik Raouf | N-acetyl-dl-leucine medicament neuro et retino protecteur |
| CA2803166C (en) | 2010-06-25 | 2023-03-07 | Shire Human Genetic Therapies, Inc. | Cns delivery of therapeutic agents |
| US20140080885A1 (en) * | 2012-09-13 | 2014-03-20 | University Of South Florida (A Florida Non-Profit Corporation) | Methods of treating traumatic brain injury |
| PT3445351T (pt) * | 2016-04-19 | 2024-11-14 | Intrabio Ltd | Acetil-leucina ou um sal farmaceuticamente aceitável seu derivado para melhoria da mobilidade |
| TN2016000259A1 (en) * | 2016-06-27 | 2017-10-06 | Rekik Raouf | Salbutamol (albuterol) eye protective medicament. |
| PT3482754T (pt) | 2016-08-11 | 2021-02-03 | Intrabio Ltd | Composições farmacêuticas e utilizações contra os distúrbios de armazenamento lisossómico |
| TN2019000033A1 (fr) * | 2016-08-11 | 2020-07-15 | Intrabio Ltd | Agents thérapeutiques pour maladies neurodégénératives |
| US20190046486A1 (en) * | 2017-08-14 | 2019-02-14 | Axcella Health Inc. | Compositions and methods for the treatment of neuronal injury |
-
2020
- 2020-03-02 CN CN202411228005.XA patent/CN119097618A/zh active Pending
- 2020-03-02 BR BR112021017203A patent/BR112021017203A2/pt unknown
- 2020-03-02 DK DK20712029.6T patent/DK3934637T3/da active
- 2020-03-02 PT PT207120296T patent/PT3934637T/pt unknown
- 2020-03-02 KR KR1020217031422A patent/KR102941068B1/ko active Active
- 2020-03-02 RS RS20240913A patent/RS65849B1/sr unknown
- 2020-03-02 SG SG11202109512SA patent/SG11202109512SA/en unknown
- 2020-03-02 MX MX2021010568A patent/MX2021010568A/es unknown
- 2020-03-02 IL IL321899A patent/IL321899A/en unknown
- 2020-03-02 SM SM20240334T patent/SMT202400334T1/it unknown
- 2020-03-02 WO PCT/IB2020/051767 patent/WO2020178721A1/en not_active Ceased
- 2020-03-02 EP EP24188941.9A patent/EP4464378A3/en active Pending
- 2020-03-02 US US17/435,784 patent/US20220142959A1/en active Pending
- 2020-03-02 PL PL20712029.6T patent/PL3934637T3/pl unknown
- 2020-03-02 MD MDE20220032T patent/MD3934637T2/ro unknown
- 2020-03-02 SI SI202030476T patent/SI3934637T1/sl unknown
- 2020-03-02 HU HUE20712029A patent/HUE068527T2/hu unknown
- 2020-03-02 EP EP20712029.6A patent/EP3934637B1/en active Active
- 2020-03-02 HR HRP20241150TT patent/HRP20241150T1/hr unknown
- 2020-03-02 AU AU2020231189A patent/AU2020231189B2/en active Active
- 2020-03-02 LT LTEPPCT/IB2020/051767T patent/LT3934637T/lt unknown
- 2020-03-02 CA CA3131948A patent/CA3131948A1/en active Pending
- 2020-03-02 MA MA55199A patent/MA55199B1/fr unknown
- 2020-03-02 KR KR1020257040124A patent/KR20250171484A/ko active Pending
- 2020-03-02 CN CN202080029158.5A patent/CN114040757B/zh active Active
- 2020-03-02 ES ES20712029T patent/ES2990183T3/es active Active
- 2020-03-02 IL IL285870A patent/IL285870B2/en unknown
- 2020-03-02 JP JP2021551939A patent/JP7555346B2/ja active Active
- 2020-03-02 FI FIEP20712029.6T patent/FI3934637T3/fi active
-
2021
- 2021-09-02 MX MX2024015063A patent/MX2024015063A/es unknown
-
2024
- 2024-09-10 JP JP2024155453A patent/JP2024170602A/ja active Pending
-
2025
- 2025-06-30 AU AU2025204995A patent/AU2025204995A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20241150T1 (hr) | (n-)acetil-l-leucin za uporabu u liječenju traumatske ozljede mozga | |
| JP2022522819A5 (cg-RX-API-DMAC10.html) | ||
| FI4084791T3 (fi) | Spesifisiä tryptamiinejä käytettäviksi mielialahäiriöiden hoidossa | |
| EP4424328A3 (en) | Treatment of hidradenitis suppurativa using jak inhibitors | |
| RU2017121191A (ru) | Методика размножения гамма-дельта Т-клеток | |
| RU2016141570A (ru) | Комбинации ингибитора fgfr и ингибитора igf1r | |
| Kalita et al. | State-of-the-art review-A review on snake venom-derived antithrombotics: Potential therapeutics for COVID-19-associated thrombosis? | |
| WO2017011356A3 (en) | Mcj inhibitors for use in treating drug-induced diseases and conditions | |
| ATE290525T1 (de) | Acylaminoalkyl-substituierte benzolsulfonamidderivate | |
| ES440982A1 (es) | Instalacion para el tratamiento de superficies de piezas a trabajar, especialmente para el lavado de piezas metalicas. | |
| WO2023114557A3 (en) | METHODS OF TREATING SUBSTANCE USE DISORDERS USING 5-MeO-DMT | |
| WO2025137652A3 (en) | Compositions comprising radiprodil and the use of radiprodil in the treatment of epileptic or neurobehavioral disorders | |
| EP3048886B1 (en) | 3, 4-bis-benzylsulfonylbutanenitrile and its pharmaceutical use | |
| CN107485791A (zh) | 一种利用积分波微磁场的偏头痛治疗仪 | |
| CERA | Emetine toxicity with electrocardiographic abnormalities | |
| Rabinovich et al. | Functional cardiovascular assessment in dentists performing local anesthesia in out-patient settings | |
| MX2023006863A (es) | Uso de la cladribina en el tratamiento de enfermedades neurológicas autoinmunes. | |
| RU2016147455A (ru) | Способ лечения кожных проявлений склеродермии | |
| Serdyuk et al. | Development of the combined medication composition for symptomatic pseudorheumatism treatment | |
| RU2003135781A (ru) | Способ лечения ревматоидного артрита | |
| GOETTE et al. | Liquid nitrogen in the treatment of acne vulgaris: a comparative study | |
| Carvalho et al. | Modulation of adult neurogenesis by the nitric oxide system | |
| Yang | OBSERVATION OF THE IMMEDIATE EFFECT OF ELECTROACUPUNCTURE AT “LINGTAI” AND “SHENDAO” POINTS ON ST-T SEGMENT OF EKG IN PATIENTS WITH CORONARY HEART DISEASE | |
| RU161528U1 (ru) | Способ комплексного лечения больных бляшечным псориазом | |
| RU2007106415A (ru) | Способ лечения тяжелой формы вульгарных угрей |